Efficacy of a VR Paradigm to Reduce Fear of Heights in a Clinical and Subclinical Population With Fear of Heights

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

May 24, 2019

Study Completion Date

May 24, 2019

Conditions
Fear of Heights
Interventions
OTHER

VR App

Participants will be exposed in three different virtual height scenarios (rural mountain, urban town, cloudy weather). At the beginning of each exposure session participants will be standing on a virtual platform at ground level (level 0). From level 0 they will proceed to further levels according to a predefined exposure scheme based on SUDS ratings (scale 0=no fear to 10=extreme fear). Participants will have to stay at each level until their SUDS are 3 or below for two times consecutively (assessment via gaze selection). In each scenario there will be 15 different height levels available (corresponding to a range of heights between 1-75m). Each exposure session will be terminated by a time limit of 20 minutes (study phase 1) or 30 minutes (study phase 2) irrespective of achieved level.

Trial Locations (1)

4055

University of Basel, Division of Cognitive Neuroscience, Basel

All Listed Sponsors
lead

Prof. Dominique de Quervain, MD

OTHER

NCT04003753 - Efficacy of a VR Paradigm to Reduce Fear of Heights in a Clinical and Subclinical Population With Fear of Heights | Biotech Hunter | Biotech Hunter